Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
IVT PCV-25 Dose-Ranging Study in Healthy Adults
NCT06077656Phase 2Completed
- Sponsor
- Inventprise
- Start
- Oct 2023
- Primary completion
- May 2024
- Modality
- Split/Subunit Vaccines
- Countries
- 1
01
Overview
A Phase 2 trial of IVT PCV-25 in pneumococcal disease, sponsored by Inventprise. Started Oct 2023; status: completed.
02
Drugs
IVT PCV-25
03
Conditions
pneumococcal disease
Beyond the preview
Go deeper on NCT06077656.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06077656.